| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Maravai Lifesciences Holdings, Inc.
13G/A
Amendment 4
MRVI · 56600D107
|
2.5% |
8/13/2026
Event 6/30/2026
|
|||
| Hudson View Holdings LLC | 0.5% | ||||
| Hudson View Capital LLC | 0.5% | ||||
| JD Squared Holdings II LLC | 2.0% | ||||
| JD Squared Capital II LLC | 2.0% | ||||
| Stuart Feldman | 2.5% | ||||
| Matthew Barkoff | 0.2% | ||||
| Joshua Wool | <0.1% | ||||
|
Maravai Lifesciences Holdings, Inc.
13G/A
Amendment 3
MRVI · 56600D107
|
7.1% |
5/14/2026
Event 3/31/2026
|
|||
| Hudson View Holdings LLC | 5.0% | ||||
| Hudson View Capital LLC | 5.0% | ||||
| JD Squared Holdings II LLC | 2.1% | ||||
| JD Squared Capital II LLC | 2.1% | ||||
| Stuart Feldman | 7.1% | ||||
| Matthew Barkoff | 1.9% | ||||
| Joshua Wool | 0.2% | ||||
|
Maravai Lifesciences Holdings, Inc.
13G/A
Amendment 2
MRVI · 56600D107
|
5.5% |
2/13/2026
Event 12/31/2025
|
|||
| Hudson View Holdings LLC | 3.4% | ||||
| Hudson View Capital LLC | 3.4% | ||||
| JD Squared Holdings II LLC | 2.1% | ||||
| JD Squared Capital II LLC | 2.1% | ||||
| Stuart Feldman | 5.5% | ||||
| Matthew Barkoff | 1.6% | ||||
| Joshua Wool | 0.2% | ||||
|
Maravai Lifesciences Holdings, Inc.
13G/A
Amendment 1
MRVI · 56600D107
|
6.2% |
11/14/2025
Event 9/30/2025
|
|||
| Hudson View Holdings LLC | 4.1% | ||||
| Hudson View Capital LLC | 4.1% | ||||
| JD Squared Holdings II LLC | 2.1% | ||||
| JD Squared Capital II LLC | 2.1% | ||||
| Stuart Feldman | 6.2% | ||||
| Matthew Barkoff | 1.9% | ||||
| Joshua Wool | 0.2% | ||||
|
Maravai Lifesciences Holdings, Inc.
13G
MRVI · 56600D107
|
4.8% |
5/29/2025
Event 5/21/2025
|
|||
| Hudson View Holdings LLC | 3.4% | ||||
| Hudson View Capital LLC | 3.4% | ||||
| JD Squared Holdings II LLC | 1.4% | ||||
| JD Squared Capital II LLC | 1.4% | ||||
| Stuart Feldman | 4.8% | ||||
| Matthew Barkoff | 1.6% | ||||
| Joshua Wool | 0.2% | ||||
|
Mural Oncology plc
13G
MURA · G63365103
|
4.4% |
5/14/2025
Event 4/16/2025
|
|||
| Hudson View Holdings LLC | 4.4% | ||||
| Hudson View Capital LLC | 4.4% | ||||
| Stuart Feldman | 4.4% | ||||
| Matthew Barkoff | 1.1% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.